Table_1_A Novel mcr-1 Variant Carried by an IncI2-Type Plasmid Identified From a Multidrug Resistant Enterotoxigenic Escherichia coli.XLSX
In this study, we discovered a novel mobilized colistin resistance (mcr-1) gene variant, named mcr-1.9, which was identified in a colistin-resistant enterotoxigenic Escherichia coli (ETEC) strain from a clinical diarrhea case. The mcr-1.9 gene differs from mcr-1 at position 1036 due to a single nucleotide polymorphism (G→A), which results in an aspartic acid residue being replaced by an asparagine residue (Asp346→Asn) in the MCR-1 protein sequence. Antimicrobial susceptibility testing showed that the mcr-1.9-harboring ETEC strain is resistant to colistin at a minimum inhibitory concentration of 4 μg/ml. Plasmid profiling and conjugation experiments also suggest that the mcr-1.9 variant can be successfully transferred into the E. coli strain J53, indicating that the gene is located on a transferable plasmid. Bioinformatics analysis of data obtained from genome sequencing indicates that the mcr-1.9 gene is located on a 64,005 bp plasmid which has been named pEC26. This plasmid was found to have high similarity to the mcr-1-bearing IncI2-type plasmids pWF-5-19C (99% identity and 99% coverage) and pmcr1-IncI2 (99% identity and 98% coverage). The mcr-1.9-harboring ETEC also shows multidrug resistance to nine classes of antibiotics, and contains several virulence and antimicrobial-resistance genes suggested by the genome sequence analysis. Our report is the first to identify a new mcr-1 variant in an ETEC isolated from a human fecal sample, raising concerns about the existence of more such variants in human intestinal flora. Therefore, we believe that an undertaking to identify new mcr-1 variants in the bacterial communities of human intestines is of utmost importance, and that measures need to be taken to control the spread of mcr-1 and its variants in human intestinal microflora.
History
References
- https://doi.org//10.1093/jac/29.3.349
- https://doi.org//10.1186/1471-2164-9-75
- https://doi.org//10.1016/j.vaccine.2016.02.076
- https://doi.org//10.1086/599374
- https://doi.org//10.1101/gr.2289704
- https://doi.org//10.1128/JCM.02473-10
- https://doi.org//10.1128/AAC.01075-16
- https://doi.org//10.1128/CMR.00052-05
- https://doi.org//10.1093/jac/dkw093
- https://doi.org//10.1016/S1473-3099(16)00056-6
- https://doi.org//10.1016/S1473-3099(16)00009-8
- https://doi.org//10.1016/j.ijantimicag.2016.02.011
- https://doi.org//10.1128/AAC.00550-16
- https://doi.org//10.1093/jac/dkw509
- https://doi.org//10.1128/AAC.01444-16
- https://doi.org//10.1016/S1473-3099(15)00424-7
- https://doi.org//10.1016/S1473-3099(15)00424-7
- https://doi.org//10.1128/AAC.02632-16
- https://doi.org//10.1128/AAC.02155-12
- https://doi.org//10.1517/14656566.2013.763030
- https://doi.org//10.1016/S1473-3099(16)00014-1
- https://doi.org//10.1093/cid/ciw124
- https://doi.org//10.2807/1560-7917.ES.2016.21.6.30135
- https://doi.org//10.1128/aac.00127-17
- https://doi.org//10.1128/cmr.18.3.465-483.2005
- https://doi.org//10.1089/fpd.2006.3.59
- https://doi.org//10.1016/S0732-8893(01)00357-1
- https://doi.org//10.1128/AAC.00056-17
- https://doi.org//10.1186/s12915-016-0303-0
- https://doi.org//10.1093/bioinformatics/btr039
- https://doi.org//10.1016/S1473-3099(16)00008-6
- https://doi.org//10.1371/journal.pone.0180347
- https://doi.org//10.1128/aac.38.10.2477
- https://doi.org//10.1016/S0140-6736(00)02451-X
- https://doi.org//10.2807/1560-7917.ES.2016.21.27.30280
- https://doi.org//10.1128/AAC.01204-16
- https://doi.org//10.1093/jac/dkw243
- https://doi.org//10.3389/fmicb.2017.02094
- https://doi.org//10.1128/AAC.05168-14